IQVIA (IQV)
(Delayed Data from NYSE)
$229.04 USD
-5.04 (-2.15%)
Updated May 13, 2024 04:00 PM ET
After-Market: $229.11 +0.07 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
IQVIA Holdings (IQV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$267.00 | $300.00 | $220.00 | 14.06% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for IQVIA Holdings comes to $267.00. The forecasts range from a low of $220.00 to a high of $300.00. The average price target represents an increase of 14.06% from the last closing price of $234.08.
Analyst Price Targets (18)
Broker Rating
IQVIA Holdings currently has an average brokerage recommendation (ABR) of 1.34 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 19 brokerage firms. The current ABR compares to an ABR of 1.34 a month ago based on 19 recommendations.
Of the 19 recommendations deriving the current ABR, 15 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 78.95% and 5.26% of all recommendations. A month ago, Strong Buy made up 78.95%, while Buy represented 5.26%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 15 | 14 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.34 | 1.34 | 1.34 | 1.34 | 1.36 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/3/2024 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
5/3/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
5/3/2024 | Truist Securities | Jailendra Singh | Strong Buy | Strong Buy |
5/2/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
2/27/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Strong Buy |
2/15/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Hold |
10/10/2023 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.34 |
ABR (Last week) | 1.34 |
# of Recs in ABR | 19 |
Average Target Price | $267.00 |
LT Growth Rate | 9.90% |
Industry | Medical - Instruments |
Industry Rank by ABR | 100 of 252 |
Current Quarter EPS Est: | 2.61 |